Healthcare, Regulatory and Reimbursement Landscape - Turkey
1. Healthcare, Regulatory and Reimbursement Landscape - Turkey
Report Details:
Published:November 2012
No. of Pages: 169
Price: Single User License – US$1995
Healthcare, Regulatory and Reimbursement Landscape - Turkey
Summary
GlobalData, the industry analysis specialist, has released its latest report, “Healthcare, Regulatory
and Reimbursement Landscape - Turkey”. It is an essential source of information and analysis on
Turkey’s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the
healthcare market and provides insights into the demographic, regulatory and reimbursement
landscape and healthcare infrastructure. Most importantly, the report provides valuable insights
into the trends and segmentation of the pharmaceutical and medical device markets. It is built
using data and information sourced from proprietary databases, secondary research and in-house
analysis by GlobalData’s team of industry experts.
The population of Turkey has increased significantly over the years. In 2011, Turkey had a
population of approximately 74 million. The overall population increased between 2006 and 2011
from 69.4 to 74.0 million, mainly due to the increasing life expectancy. In 2011, Turkey was the
17th most populated nation in the world. As is the case in most developed countries, the elderly
population is increasing and in 2012 comprises more than 10% of the population. The working age
group contributes more than 50% of the total population and is expected to reach 56.3% of the
total population by 2020, resulting in an increase in the available labor pool in the country.
In 2010, the pharmaceutical market of Turkey was approximately $9.8 billion and Turkey was the
sixth largest pharmaceutical market in Europe. The pharmaceutical market is to grow at a
Compound Annual Growth Rate (CAGR) of 6.1% from 2005 to 2020, and is estimated to reach
$21.6 billion in 2020.
The market for medical devices in Turkey is large due to the increasing elderly population and
subsequent increase in the demand for healthcare products and services. The medical device
market in Turkey was valued at approximately $1.8 billion in 2006. It grew at a CAGR of 4.8% from
2006 to 2011 and reached $2.2 billion in 2011. The market is predicted to reach to $3.3 billion by
2020. Turkey predominantly depends on imports for the medical devices. Turkey has a large
number of domestic producers also but these are involved with products which do not require high
2. technology.
Scope
- Overview of Turkey’s pharmaceutical and medical device markets, including size, segmentation
and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical and medical device
markets. Key players in the pharmaceutical market are Abdi Ibrahim, Novartis, Sanofi, Bilim and
Pfizer. Key players in the medical devices market are Siemens Healthcare, Roche, Essilor,
Fresenius and Baxter.
- Insightful review of the reimbursement and regulatory landscape, comprising details of the
healthcare reimbursement process, regulatory agencies and approval processes for new drugs
and medical devices
- Detailed analysis of Turkey’s political and economic environment, including economic indicators,
demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the healthcare market
Reasons to buy
This report comprehensively covers Turkey’s pharmaceutical and medical device markets and will
enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Turkey’s
healthcare market
- Drive revenues by understanding key trends, reimbursement and regulatory policies,
pharmaceutical and medical device market segments and companies likely to impact the
healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape
and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments
that present the most opportunities for consolidation, investment and strategic partnerships
- Identify, understand and capitalize on the opportunities and challenges in Turkey’s healthcare
market
Get your copy of this report @
http://www.reportsnreports.com/reports/209355-healthcare-regulatory-and-reimbursement-landscape-turkey.html
Major points covered in Table of Contents of this report include
1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 11
2.1 Report Guidance 11
3. 3 Overview of Pharmaceutical and Medical Devices Markets 12
3.1 Pharmaceutical Market 12
3.1.1 Market Overview 12
3.1.2 Supply Channels 14
3.1.3 Market Segments 15
3.1.4 Major Therapeutic Areas 20
3.1.5 Major Players 22
3.2 Medical Device Market 47
3.2.1 Market Overview 47
3.2.2 Overview of Top Five Segments 49
3.2.3 Major Players 60
3.3 Market Drivers and Barriers 83
3.3.1 Market Drivers 83
3.3.2 Market Barriers 83
4 Market Access 85
4.1 Reimbursement and Payer Landscape 85
4.1.1 Overview of Healthcare System 85
4.1.2 Reimbursement Process 88
4.1.3 Overview of Insurance Providers 89
4.1.4 Patient Share in Healthcare Spending 90
4.1.5 Pricing Trends in Healthcare Industry 91
4.1.6 Pricing Policies 91
4.2 Regulatory Landscape 92
4.2.1 Overview of Regulatory Agencies 92
4.2.2 Drug Approval Process 92
4.2.3 New Device Approval Process 94
4.2.4 Licensing Process for Manufacturing 95
4.2.5 Licensing Process for Pharmaceutical Imports 96
4.2.6 Intellectual Property Rights Landscape 96
4.2.7 Clinical Trial Regulations 96
4.2.8 Pharmaceutical Advertising Regulations 97
4.2.9 Pharmacy Regulations 98
4.2.10 Labeling and Packing Regulations 99
5 Country Analysis 100
5.1 Political Environment 100
5.1.1 Political Structure 100
5.1.2 Analysis of the Current Political Environment 101
5.1.3 Healthcare Policy Initiatives 102
5.2 Economic Landscape 103
5.3 Economic Indicators 104
5.3.1 Gross Domestic Product 104
5.3.2 Gross National Income 106
4. 5.3.3 Inflation 107
5.3.4 Currency Exchange Rate 110
5.3.5 Foreign Direct Investment 111
5.3.6 Foreign Exchange Reserves 112
5.3.7 Trade Balance 113
5.3.8 Government Structural Balance 115
5.3.9 Government Net Debt 116
5.3.10 Major Industries 117
5.4 Demographics 118
5.4.1 Population 118
5.4.2 Education and Literacy 133
5.4.3 Employment 136
5.4.4 Disease Burden 138
5.5 Healthcare Infrastructure 139
5.5.1 Healthcare Facilities 139
5.5.2 Healthcare Parameters 142
5.5.3 Environmental Health 144
5.5.4 Healthcare Personnel 148
5.6 Healthcare Expenditure 151
5.6.1 Overview 151
5.6.2 Health and Drug Expenditure 153
5.6.3 Health Expenditure Per Capita 155
5.6.4 Public and Private Sector Share 156
5.6.5 Spending on Pharmaceutical R&D 157
5.7 Trade Associations 158
5.7.1 Turkish Pharmacists’ Association 158
5.7.2 Pharmaceutical Manufacturer’s Association of Turkey 158
5.7.3 Turkish Confederation of Employer Associations 158
5.8 Trade Fairs 159
6 Opportunities and Challenges 160
6.1 Opportunities 160
6.2 Challenges 161
7 Appendix 162
7.1 Abbreviations 162
7.2 Bibliography 163
7.3 Methodology 167
7.3.1 Coverage 167
7.3.2 Secondary Research 167
7.3.3 Forecasting 168
7.3.4 Primary Research 168
7.3.5 Expert Panel Validation 168
7.4 Contact Us 168